76075-103 : Kyprolis 10 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution

Labeler: Onyx Pharmaceuticals, Inc.
Product Type: Human Prescription Drug
Drug Name:  Kyprolis
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: NDA202714
Rev. Date: 

NDC Package Codes:

  • 76075-103-01: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (76075‑103‑01) > 10 ML IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Carfilzomib

Dosage Strength:

  • 10 mg/5mL

Pharmaceutical Classes:

  • Proteasome Inhibitor [EPC]
  • Proteasome Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 76075-101 Kyprolis 60 mg/30ml Intravenous Injection, Powder, Lyophilized, for Solution by Onyx Pharmaceuticals, Inc.
  • 76075-102 Kyprolis 30 mg/15ml Intravenous Injection, Powder, Lyophilized, for Solution by Onyx Pharmaceuticals, Inc.


Scan the QR code below to easily reference this data in the future:

NDC 76075-103 QR Code

< Prev: 76075-102Next: 76077-100 >

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 June 2018.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA